Clinical Trial Update: Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Ro 50-3821 to treat anemia in patients with stage IIIB or IV non-small cell lung cancer receiving antineoplastic therapy; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Non-small Cell Lung Cancer

Drugs mentioned

• Ro 50-3821

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Anemia, Lung Cancer | Phase 2 | Status: COMPLETED